- Home
- EIG vs ORIC Comparison
EIG vs ORIC Comparison
Compare EIG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIG | ORIC |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.0M | 1.2B |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EIG | ORIC |
|---|---|---|
| Price | $39.59 | $12.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 264.8K | ★ 1.4M |
| Earning Date | 05-22-2026 | 05-18-2026 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $858,700,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.76 | N/A |
| P/E Ratio | $86.11 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.73 | $3.90 |
| 52 Week High | $51.23 | $14.93 |
Technical Indicators
Market Signals| Indicator | EIG | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 53.16 |
| Support Level | $38.29 | $11.74 |
| Resistance Level | $43.30 | $12.66 |
| Average True Range (ATR) | 1.59 | 0.96 |
| MACD | -0.13 | -0.09 |
| Stochastic Oscillator | 31.51 | 47.26 |
Price Performance
Historical ComparisonAbout EIG Employers Holdings Inc
Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.